FGHQF.US Frontage Holdings Corporation

Healthcare Biotechnology USA Stocks
0.1750 USD
Close of Nov 12, 2026
0.1100 0.2001
Market cap
USD 356M
P/E
17.5x
P/B
1.00x
ROE
7.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is FGHQF.US undervalued?

Graham number
Price0.1750
Graham value0.1981
Discount11.7%

FGHQF.US trades 11.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Frontage Holdings Corporation fundamental analysis

No fundamental analysis for Frontage Holdings Corporation yet.

Frontage Holdings Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Frontage Holdings Corporation

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early p…

Full company profile